Patents on Biotechnological Inventions: The European Directive
Published on 27. December 2001
Book
Hardback
256 pages
978-0-7520-0706-9 (ISBN)
Description
This Special Report provides IP lawyers and patent agents with authoritative, reliable guidance on a complex area of law and practice. The growth of biotechnology has exploded since the 1980s, and the major players - governments, industrialists and investors - have welcomed a review of the regulatory regime that governs the patents arising from biotechnology R&D. The current EC directive addresses their concerns, and aims to harmonise national patent laws in the EU and provide clear policies on patenting of biotechnology which will be applied in all member states.
The authors, both acknowledged experts in the field, provide an authoritative analysis of this complex area of law. They also thoroughly examine the patenting and ethical issues relating to biological material. Their practical and timely treatment discusses previous leading cases and suggests how they would be decided in the light of the Directive: effectively providing guidance for those drafting similar patents now.
* Unique clarification of a complex area of law and practice
* Reliable guidance on patenting and ethical issues facing the industry
* Analyses and compares US biotech patenting regime with UK
* Sets out the full text of the EC Directive and related materials
This Special Report provides IP lawyers and patent agents with authoritative, reliable guidance on a complex area of law and practice. The growth of biotechnology has exploded since the 1980s, and the major players - governments, industrialists and investors - have welcomed a review of the regulatory regime that governs the patents arising from biotechnology R&D. The current EC directive addresses their concerns, and aims to harmonise national patent laws in the EU and provide clear policies on patenting of biotechnology which will be applied in all member states.
The authors, both acknowledged experts in the field, provide an authoritative analysis of this complex area of law. They also thoroughly examine the patenting and ethical issues relating to biological material. Their practical and timely treatment discusses previous leading cases and suggests how they would be decided in the light of the Directive: effectively providing guidance for those drafting similar patents now.
* Unique clarification of a complex area of law and practice
* Reliable guidance on patenting and ethical issues facing the industry
* Analyses and compares US biotech patenting regime with UK
* Sets out the full text of the EC Directive and related materials
The authors, both acknowledged experts in the field, provide an authoritative analysis of this complex area of law. They also thoroughly examine the patenting and ethical issues relating to biological material. Their practical and timely treatment discusses previous leading cases and suggests how they would be decided in the light of the Directive: effectively providing guidance for those drafting similar patents now.
* Unique clarification of a complex area of law and practice
* Reliable guidance on patenting and ethical issues facing the industry
* Analyses and compares US biotech patenting regime with UK
* Sets out the full text of the EC Directive and related materials
This Special Report provides IP lawyers and patent agents with authoritative, reliable guidance on a complex area of law and practice. The growth of biotechnology has exploded since the 1980s, and the major players - governments, industrialists and investors - have welcomed a review of the regulatory regime that governs the patents arising from biotechnology R&D. The current EC directive addresses their concerns, and aims to harmonise national patent laws in the EU and provide clear policies on patenting of biotechnology which will be applied in all member states.
The authors, both acknowledged experts in the field, provide an authoritative analysis of this complex area of law. They also thoroughly examine the patenting and ethical issues relating to biological material. Their practical and timely treatment discusses previous leading cases and suggests how they would be decided in the light of the Directive: effectively providing guidance for those drafting similar patents now.
* Unique clarification of a complex area of law and practice
* Reliable guidance on patenting and ethical issues facing the industry
* Analyses and compares US biotech patenting regime with UK
* Sets out the full text of the EC Directive and related materials
Reviews / Votes
''This book provides a clear analysis of the Directive, from its inception to the present time.'' ''...this book will provide you with useful guidance on the current state of the law in the E.U., end where the law is still to be made.''.''This book provides a clear analysis of the Directive, from its inception to the present time.'' ''...this book will provide you with useful guidance on the current state of the law in the E.U., end where the law is still to be made.''.
More details
Language
English
Place of publication
London
United Kingdom
Publishing group
Sweet & Maxwell Ltd
Target group
College/higher education
Professional and scholarly
ISBN-13
978-0-7520-0706-9 (9780752007069)
Copyright in bibliographic data is held by Nielsen Book Services Limited or its licensors: all rights reserved.
Schweitzer Classification
Content
Purpose. Legal background. Provisions relating to patentability. Scope of protection. Exhaustion of rights and compulsory licensing. Practical implications of the Directive. Comparison with the position in the USA. Implementation. Annexes.